Helix BioMedix, Inc. (OTCPK:HXBM) announced that it will receive $5,625,120 in funding on July 15, 2019. The company will issue convertible debt and option, warrant or other right to acquire another security in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.